These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2580513)

  • 1. Effect of the calcium entry blocker, flunarizine, on ruthenium red uptake by endothelial cells following acute electrical stimulation of rabbit carotid arteries.
    Viele D; Betz E
    Basic Res Cardiol; 1985; 80(1):59-65. PubMed ID: 2580513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of smooth muscle cell proliferation and endothelial permeability with flunarizine in vitro and in experimental atheromas.
    Betz E; Hämmerle H; Strohschneider T
    Res Exp Med (Berl); 1985; 185(4):325-40. PubMed ID: 4048654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Densitometric measurement of increased endothelial permeability in arteriosclerotic plaques and inhibition of permeability under the influence of two calcium antagonists.
    Strohschneider T; Betz E
    Atherosclerosis; 1989 Feb; 75(2-3):135-44. PubMed ID: 2712859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced oxygen uptake and lactate production of smooth muscle cell proliferates of rabbit carotid arteries.
    Knehr HE; Heinle H; Betz E
    Pflugers Arch; 1980 Aug; 387(1):73-7. PubMed ID: 7191108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of the effect of flunarizine on rabbit isolated vascular muscle.
    Wadsworth RM; Moss JP
    Eur J Pharmacol; 1982 Nov; 85(2):207-9. PubMed ID: 7151868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker.
    De Clerck F; Loots W; Somers Y; Van Gorp L; Verheyen A; Wouters L
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):4-23. PubMed ID: 2990365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity of calcium-dependent endothelial stimulation in rat isolated aorta to the calcium entry blocker, flunarizine.
    Miller RC; Schoeffter P; Stoclet JC
    Br J Pharmacol; 1985 Jun; 85(2):481-7. PubMed ID: 2992665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular reactivity and calcium-entry blockers.
    Van Nueten JM; De Clerck F
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():575-83. PubMed ID: 6233852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-mediated vascular contractions. Inhibition by flunarizine, a calcium-entry blocker.
    De Clerck F; Van Nueten JM
    Biochem Pharmacol; 1983 Mar; 32(5):765-71. PubMed ID: 6404280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis, calcium, and calcium antagonists.
    Henry PD
    Circulation; 1985 Sep; 72(3):456-9. PubMed ID: 3893790
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
    Kubo K; Matsuda Y; Kase H; Yamada K
    Biochem Biophys Res Commun; 1984 Oct; 124(2):315-21. PubMed ID: 6093793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin synthesis by proliferative aortic smooth muscle cells.
    Larrue J; Bricaud H; Sinzinger H
    Vasa; 1984; 13(4):311-8. PubMed ID: 6393627
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of flunarizine on the distribution of calcium in vascular smooth muscle.
    Borgers M; Ghoos E; Thoné F; Van Nueten JM
    Blood Vessels; 1980; 17(3):123-30. PubMed ID: 6770932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries.
    Godfraind T; Dieu D
    J Pharmacol Exp Ther; 1981 May; 217(2):510-5. PubMed ID: 7229987
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation by endothelium of contractile responses in rat aorta in absence and presence of flunarizine.
    Miller RC; Stoclet JC
    Br J Pharmacol; 1985 Nov; 86(3):655-61. PubMed ID: 3864514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced endothelial permeability and invasion of leukocytes into the artery wall as initial events in experimental arteriosclerosis.
    Kling D; Holzschuh T; Strohschneider T; Betz E
    Int Angiol; 1987; 6(1):21-8. PubMed ID: 3624943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by flunarizine against endothelial cell injury in vivo.
    Hladovec J; De Clerck F
    Angiology; 1981 Jul; 32(7):448-62. PubMed ID: 7247070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flunarizine, a calcium influx blocker, inhibits TRH-but not potassium-stimulated prolactin secretion.
    Merritt JE; Tomlinson S; Brown BL
    Acta Endocrinol (Copenh); 1984 Sep; 107(1):31-5. PubMed ID: 6435368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective abolition of Ca-dependent responses of smooth and cardiac muscles by flunarizine.
    Nakayama K; Kasuya Y
    Jpn J Pharmacol; 1980 Oct; 30(5):731-42. PubMed ID: 7206379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.